A Bioequivalence Study of Different Formulations of SEP-190 and Food Effect Study in Japanese Healthy Adult Males.
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2013
At a glance
- Drugs Eszopiclone (Primary)
- Indications Depressive disorders; Generalised anxiety disorder; Insomnia
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 11 Feb 2013 Primary endpoints amended as reported by ClinicalTrials.gov.
- 08 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2010 New trial record